Current Dengue Virus Vaccine Developments and Future Directions
Dengue fever (DF), a leading arboviral disease globally, is caused by the Dengue virus (DENV) and represents a significant public health concern, with an estimated 390 million cases reported annually. Due to the complexity of the various dengue variants and the severity of the disease, vaccination e...
Saved in:
| Main Authors: | Govindaraj Anumanthan, Bikash Sahay, Ayalew Mergia |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Viruses |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4915/17/2/212 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TAK-003: development of a tetravalent dengue vaccine
by: Xavier Sáez-Llorens, et al.
Published: (2025-12-01) -
The Immunogenicity and Safety of CYD-Tetravalent Dengue Vaccine (CYD-TDV) in Children and Adolescents: A Systematic Review
by: Raksheeth Agarwal, et al.
Published: (2017-05-01) -
The Immunogenicity and Safety of CYD-Tetravalent Dengue Vaccine (CYD-TDV) in Children and Adolescents: A Systematic Review
by: Raksheeth Agarwal, et al.
Published: (2017-05-01) -
Problematic questions in the development of specific prevention of dengue fever
by: E. I. Kazachinskaia, et al.
Published: (2022-03-01) -
Current status of the development of dengue vaccines
by: Michelle Felicia Lee, et al.
Published: (2025-01-01)